GLIOMA
Clinical trials for GLIOMA explained in plain language.
Never miss a new study
Get alerted when new GLIOMA trials appear
Sign up with your email to follow new studies for GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Brain cancer drug trial halted after just two patients
Disease control TerminatedThis study tested a new drug called VAL-083 in people with glioblastoma, an aggressive brain cancer, that had come back after standard treatments. The goal was to see if VAL-083 could help patients live longer. However, the trial was stopped early after only 2 people enrolled, so…
Matched conditions: GLIOMA
Phase: PHASE3 • Sponsor: DelMar Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Experimental combo therapy for aggressive brain tumors shows promise in early trial
Disease control TerminatedThis study tested a special type of radiation (pulse reduced dose rate) combined with the drug bevacizumab in 49 people whose high-grade glioma (a serious brain tumor) had come back after standard treatment. The goal was to see if this combination could help people live longer an…
Matched conditions: GLIOMA
Phase: PHASE2 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated May 11, 2026 20:39 UTC
-
Wakefulness drug studied for brain tumor fatigue
Symptom relief TerminatedThis study tested a drug called solriamfetol to see if it could help people with brain tumors (gliomas) feel more awake and improve their memory, mood, and quality of life. Only 2 people enrolled before the study was stopped early. The main goal was to check for side effects.
Matched conditions: GLIOMA
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated May 16, 2026 23:47 UTC
-
Brain tumor drug penetration study halted early
Knowledge-focused TerminatedThis early-phase trial aimed to see how well the drug infigratinib reaches brain tumors in patients with recurrent high-grade glioma (a type of brain cancer) who were scheduled for surgery. Only 7 of the planned 20 participants were enrolled before the study was terminated. The m…
Matched conditions: GLIOMA
Phase: EARLY_PHASE1 • Sponsor: Nader Sanai • Aim: Knowledge-focused
Last updated May 16, 2026 23:48 UTC
-
Antifungal drug explored as brain tumor treatment – study halted early
Knowledge-focused TerminatedThis study looked at whether the antifungal drug ketoconazole could block a protein called tGLI1 in brain tumors. It included 15 adults with breast cancer that spread to the brain or with a type of brain tumor called glioma. The goal was to see if the drug could affect the tumor'…
Matched conditions: GLIOMA
Phase: EARLY_PHASE1 • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC